Join the first ever Innovation Conference held under the auspices of the Global Africa Initiative
The Trade Connect Cambridge Conferences is just around the corner, and we’re excited to invite you to be a part of this groundbreaking event.
Cambridge Enterprise appoints new Chief Executive
Dr Jim Glasheen has been appointed as Chief Executive of Cambridge Enterprise, the innovation arm of the University of Cambridge. Dr Glasheen will assume his post later in 2024.
This year's Cambridge Dragon Boat Festival raises a staggering £35,000 for the new Cambridge Cancer Research Hospital
Over 600 participants took part in this year's Addenbrooke Charitable Trust's 18th Cambridge Dragon Boat Festival - bringing sunshine, fun and a big boost to the £14 million public appeal to see the new Cambridge Cancer Research Hospital built on the City's Biomedical Campus by 2029
Fertility needs to be the next big conversation for the workplace
“Women can have it all, but they can’t do it all themselves,” observes Dr Shreeya Tewary, Bourn Hall Consultant Gynaecologist and IVF Specialist, ahead of the Rising Festival, in Cambridge on 21 September 2024, which will be celebrating women’s ‘potential, ambition, fulfilment a
New therapy that targets and destroys tau tangles is a promising future Alzheimer’s disease treatment
Medical Research Council media release.
Nxera’s Partner Cancer Research UK to Present on Phase 1/2a Clinical Trial with Cancer Immunotherapy Drug HTL0039732 at ESMO
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist with the potential to treat a wide range of cancers in combination with other immunotherapies Cancer Research UK’s Centre for Drug
Pioneering Cambridge VR project announces London tour
Innovative virtual reality platform rapidly transforms users into confident and skilled public speakers.
Owlstone Medical celebrates success at SME Cambridgeshire Business Awards
It was a double success as the Owlstone Medical team scooped two awards. The company won Website of the Year for its OMED Health website and silver for Employer of the Year.
Approaching the final frontier: Are we in a golden decade of drug development for the central nervous system?
In this CRA Insights, the authors Will Foster, Kees Chamberlain, Joanne Clark, and Carl Lottig recount the recent scientific and technological advances in drug development in the central nervous system (CNS).
Connect: Health Tech – ‘the connectivity mix’ visual branding
For this thought leadership project ‘The connectivity mix’ we needed to create the brand for the Ecosystem Insights that can be used for all in-depth papers and short articles.
Arecor presents positive data from phase I clinical trial of ultra-concentrated ultra-rapid acting insulin AT278
- AT278 delivers significantly accelerated early PK/PD profile compared with NovoRapid® in people with Type 2 Diabetes and high BMI
Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors
Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones
Cellular Origins and 3P innovation collaborate to accelerate industrialisation of CGT manufacturing
Partnership to integrate 3P innovation’s cryoFIL cryovial filling platform within Cellular Origins’ robotic system, Constellation
Enterprise Therapeutics appoints Annabella Amatulli as Head of Regulatory Affairs
Appointment brings extensive regulatory experience as lead asset ETD001 progresses through Phase 2 clinical trial for treatment of cystic fibrosis
Engagement and motivation at work: what's the difference?
At work, you’ve probably heard people throwing around the terms “motivation” and “engagement” like they’re the same thing. Spoiler alert: They’re not. While both are crucial for driving employee performance and satisfaction, they represent distinct aspects of how we experience the workplace.
Health Innovation East and 42T webinar to help power Net Zero NHS
Health Innovation East, the innovation arm of the NHS in the East of England and 42 Technology (42T), a product design and innovation consultancy, are co-hosting a free webinar aimed at helping the NHS achieve its ambitious net zero goals.
Team’s hip replacement surgery invention is set to be world first
Technology which is the first of its kind in the world and could transform the future of hip replacement surgery is being pioneered by a team of experts in Cambridge.
HOPE: Cleanroom Solutions facilitating greatness with elite large-scale turnkey construction builds
Guardtech Group’s complex cleanroom facility construction brand celebrating their role as facilitators of groundbreaking Life Science and R&D innovation
Common diabetes drug slows growth of normal cells carrying cancer mutation
A common diabetes medication, metformin, slows the growth of precancerous cells in the oesophagus while some metabolic conditions accelerate it, suggests a new study.
PhoreMost extends Series B financing to $50M to advance high-value oncology and inflammation degrader programmes
Investment to enable progression of pipeline of novel degrader assets through pre-clinical development and support further development of GlueSEEKER™ platform Led by Parkwal
o2h technology announces the launch of the third edition of the Tech Kickstarter Competition
Cambridge, UK: o2h technology, a business vertical of the o2h group, is thrilled to announce the launch of the third edition of its Tech Kickstarter Competition.
NanoSyrinx closes c. £10 million GBP financing and appoints Dr. Edwin Moses as Chairman
Round co-led by BGF, Octopus Ventures and M Ventures, with support from new corporate investor, Eli Lilly and Company, and existing investors, IQ Capital and Meltwind <
Meet Cambridge helps to bring international neurotrauma conference to the city
The official bureau for conferences and events in Cambridge and the surrounding area is seeing the culmination of five years’ preparation as partner to the organising committee for one of the world’s largest medical conferences in its field.
Natural probiotic discovered in UK newborns' microbiomes
Newborn babies have one of three pioneer bacteria in their gut shortly after birth, one of which could be used to develop new personalised infant therapeutic probiotics, researchers show.